Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants

Project Overview

Autism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ. This suggests that many different mechanisms are causing these disorders in patients. This great diversity has hindered our progress in understanding the mechanisms leading to these psychiatric conditions and genetic information is not yet been fully used in clinical psychiatry. In this project, we intend to use recent genetic discoveries to classify patients with autism and schizophrenia. We will identify in large autism and schizophrenia cohorts from Montreal and our international collaborators, patients who carry specific genetic mutations. We will compare them to patients who have other types of mutation or no identified mutation. This study will advance our knowledge on how these particular mutations lead to psychiatric symptoms and the differences in symptoms between individuals who carry mutations in different genes. If this project is successful, we will be able to identify individuals who are at a higher risk of suffering from autism or schizophrenia and establish early interventions. We will also be able to distinguish between different forms of theses disorders to avoid applying the same therapeutic approach to all patients. These are first steps in improving personalized care in psychiatric disorders.

Principal Investigator

Sébastien Jacquemont , Sainte-Justine University Hospital Research Centre

Team Members

Laurent Mottron, Université de Montréal

Ridha Joober, McGill University

Guy Rouleau, Montreal Neurological Hospital and Institute

Alan Evans, Montreal Neurological Institute and Hospital, McGill University

Carl Ernst, Douglas Mental Health University Institute

Sylvain Baillet, McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University

Mayada Elsabbagh, McGill University

Paul Pavlidis, University of British Columbia

Sarah Lippé, Sainte-Justine University Hospital Research Centre

Emmanuelle Lemyre, Sainte-Justine University Hospital Research Centre

Partners and Donors

CHU Sainte Justine Research Centre

Université de Montréal

Montreal Neurological Institute

Project Ongoing

Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants

  • Grant Type

    Team grants

  • Area of research

    Multiple

  • Disease Area

    Autism,  Mental illness

  • Competition

    2015 MIRI Team Grants

  • Province

    Québec

  • Start Date

    2017

  • Total Grant Amount

    $1,387,500

  • Health Canada Contribution

    $693,750

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now